Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

计划入组 392 人 · 首次发布于 2017 年 10 月 30 日

A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

计划入组 81 人 · 首次发布于 2017 年 2 月 6 日

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

计划入组 60 人 · 首次发布于 2002 年 8 月 15 日

dementia vaccine

Frontotemporal dementia (TSOI)

SRXXX (Senile dementia)

The Bluefield Project To Cure Frontotemporal Dementia

United States

Alzheimer's Disease And Related Disorders Association, Inc.

United States

Alzheimer's Disease And Related Disorders Association, Georgia Chapter, Inc.

United States

Cerevel Therapeutics Advances Emraclidine Development for Alzheimer's-Related Dementia and Psychosis

Lumateperone Shows Promise in Preventing Symptomatic Relapse in Schizophrenia

Kinoxis Therapeutics Receives $2.5M Grant to Advance KNX100 for Dementia Agitation